Now I have sufficient verification of the paper content against the reviewer claims. Let me construct the final consolidated review.

---

## Summary

This paper introduces GeoBFN (Geometric Bayesian Flow Networks), applying Bayesian Flow Networks (BFNs) — a recently proposed generative modeling framework — to 3D molecule generation. Unlike diffusion models that operate in sample space, GeoBFN models continuous coordinates, discretized charges, and categorical atom types in a differentiable parameter space with SE(3)-invariant density modeling. The method achieves competitive reported numbers on QM9 and GEOM-DRUG benchmarks (e.g., 90.87% molecule stability on QM9), supports any-step sampling (50–4000 steps from a single trained model), and offers a claimed 20× speedup over diffusion baselines at low step counts.

## Strengths

- **Novel and well-motivated framework**: Applying BFNs to 3D molecule generation is a fresh direction distinct from the dominant diffusion-model paradigm. The parameter-space formulation provides a principled way to handle heterogeneous data types (continuous, discretized, categorical) that is conceptually cleaner than designing per-modality noise schedules.

- **Any-step sampling without retraining**: GeoBFN demonstrates that a single trained model can generate valid molecules across a wide range of sampling steps (50 to 4000 steps, Figure 4), with quality improving monotonically with more steps. This is a practical advantage over diffusion models that require step-count–specific noise schedules.

- **SE(3)-invariant theoretical framework**: Theorem 3.1 establishes formal conditions on the sender, receiver, Bayesian update, and prior distributions that guarantee SE(3) invariance of the generative density, and Proposition 3.2 shows the ELBO objective is SE(3) invariant under these conditions. Remark 3.3 confirms that the proposed GeoBFN satisfies these conditions, providing a principled foundation.

- **Consistently competitive empirical results**: Across both QM9 and GEOM-DRUG (Table 1) and conditional generation on QM9 properties (Table 2), GeoBFN reports the best numbers on nearly all metrics, including atom stability, molecule stability, validity, and all six conditional MAEs.

- **Modality simplification via probabilistic modeling**: The ablation study (Table 3) shows that GeoBFN can train and sample using only discretized charges (without categorical atom types) while achieving superior performance, demonstrating the modeling capacity of the BFN formulation for discretized variables.

## Weaknesses

### Fatal
None.

### Major

- **No uncertainty quantification for main results**: Tables 1 and 2 report single point estimates without standard deviations, confidence intervals, or number of independent trials. On QM9 molecule stability, GeoBFN (90.87%) leads GeoLDM (90.73%) by only 0.14 percentage points — a margin that could vanish under random seed variation. While single-run reporting is common practice in this subfield (EDM, GeoLDM, etc.), the paper makes explicit "state-of-the-art" claims, and the absence of any variance measure makes these claims unverifiable. This is the most significant evidential gap.

- **The 20× speedup claim lacks wall-clock timing**: The paper asserts a "20× speed-up during sampling" (line 286) by comparing GeoBFN at 50 steps to EDM at 1000 steps. No actual runtime (seconds per molecule), FLOPs, or per-step cost comparison is reported. If GeoBFN's EGNN forward pass is more expensive per step than EDM's, the real speedup could be substantially smaller. The speedup claim should be quantified with actual timing data.

- **Core motivation (noise sensitivity) is not empirically validated on molecules**: Section 3.3 argues that diffusion models suffer because noisy intermediates lose chemical structure, while GeoBFN's parameter-space Bayesian updates are smoother. This is supported only by qualitative reasoning and a 2D synthetic trajectory (Figure 3). No experiment compares intermediate geometries on actual molecules (e.g., RMSD to final structure at intermediate steps, bond distance preservation). This leaves a central design claim unsubstantiated.

- **The mode-seeking sampling fix (Eq. 20) is heuristic and unablated on molecular data**: Section 3.4 identifies a mode-redundancy issue for discretized variables and proposes a NEAREST_CENTER heuristic. This is a practical engineering fix with no theoretical derivation. The paper validates it only on a 2D synthetic dataset (Figure 5), not on molecular stability or validity metrics. An ablation comparing atom stability/validity with and without this fix on QM9 or GEOM-DRUG is needed to establish its practical value.

### Minor

- **Ablation study is incomplete for isolating contributions**: Table 3 tests modality compositions, but leaves out several informative comparisons: (a) replacing the BFN loss with a diffusion ELBO under the same EGNN architecture to isolate the benefit of BFNs; (b) comparing the mode-seeking fix (Eq. 20) against naïve sampling on molecular metrics; (c) ablating the equivariant network by substituting a non-equivariant MLP. While not every ablation is necessary, the absence of (a) in particular makes it unclear whether improvements come from the BFN formulation or the EGNN+training setup.

- **GEOM-DRUG baseline set is narrower than QM9**: Table 1 appears to include only EDM, EDM-Bridge, and GeoLDM on GEOM-DRUG, whereas QM9 includes G-Schnet and ENF as well. The paper lists these methods as baselines (line 266) but does not clarify why they are absent from the larger-molecule benchmark.

### Trivial
None.

## Nice-to-Haves

- Reporting standard deviations over 3+ random seeds for Tables 1 and 2.
- Measuring wall-clock sampling time (seconds per molecule) for GeoBFN and baselines at matched step counts.
- A quantitative noise-sensitivity experiment comparing intermediate structure quality (e.g., RMSD to final structure at 25%/50%/75% sampling progress) for GeoBFN vs. EDM on QM9 molecules.
- Generating failure-case analyses showing what kinds of invalid molecules GeoBFN produces and why.

## Removed Points

These points are flagged to be removed; treat them with caution.

1. **"Unified probabilistic modeling claim is misleading"** (Harsh Critic, Section-by-Section Notes — Introduction): The reviewer claims this is "standard multi-modal modeling, not a unification." This misreads the paper: the unification lies in the BFN parameter-space framework treating all modalities through the same Bayesian update mechanism, which is genuinely different from prior per-modality approaches (different noise schedules, different latent spaces). The criticism misunderstands the paper's contribution. **Removed.**

2. **"Theorem 3.1 and Proposition 3.2 stated without proof"** (Harsh Critic, Section-by-Section Notes): The paper explicitly says proofs are deferred; these would appear in the appendix, which the parser strips from all submissions. Per policy, criticisms about missing appendix content are removed. **Removed per parser-artifact rule.**

3. **Strength Finder strength #4 (Noise sensitivity mitigation)**: This strength conflicts with the verified major weakness that the noise-sensitivity claim is not empirically validated on molecules. According to the rules, "when a strength and weakness disagree, the weakness wins." **Moved here.**

4. **Strength Finder strength #5 (Optimized sampling for discretised variables)**: Claims this is "a concrete technical refinement" with "Figure 5 illustrating the improvement." This partially conflicts with the verified weakness that the fix is heuristic, unablated on molecular data, and validated only on 2D synthetic data. Retained as a minor strength in the main review but downgraded from the overly positive characterization. **Partially retained in main review; moved here in the original Strength Finder's phrasing.**

## Novel Insights

None beyond the paper's own contributions. The reviews identify evidential gaps (lack of error bars, qualitative-only validation of the core motivation) but do not contribute novel scientific insights about the method or problem domain beyond what the paper already presents.

## Suggestions

1. **Report mean and standard deviation** over at least 3 random seeds for all main metrics (Tables 1–2). This is the single most impactful improvement — it would either confirm the SOTA claims or show they are not statistically significant.

2. **Add a direct BFN-vs-diffusion ablation**: Keep the EGNN architecture identical but replace the BFN loss with a standard diffusion ELBO (EDM-style) and compare. This isolates whether the BFN framework (rather than network design or hyperparameters) is responsible for improvements.

3. **Validate the noise-sensitivity claim quantitatively**: Compare intermediate geometries (pairwise distances, RMSD to final structure) at various generation stages for GeoBFN vs. EDM on actual QM9 molecules.

4. **Report actual wall-clock sampling times** for GeoBFN and EDM/GeoLDM at comparable step counts to substantiate the 20× speedup claim.

5. **Ablate the mode-seeking fix (Eq. 20)** by comparing atom stability and validity with and without it on QM9 or GEOM-DRUG, rather than only on 2D synthetic data.

## Score and Decision

The paper introduces a novel and well-motivated application of Bayesian Flow Networks to 3D molecule generation, with a principled SE(3)-invariant formulation and the practically valuable any-step sampling property. The reported empirical results are consistently strong across multiple benchmarks. However, the submission has significant evidential gaps: the lack of any uncertainty quantification undermines the SOTA claims, the core motivation (noise sensitivity) is not empirically validated on molecules, the speedup claim lacks runtime measurements, and a key algorithmic fix is unablated on molecular data. These issues are addressable in a revision but are material in the current form. The paper's core method is sound and the contribution is novel.

**MY FINAL SCORE: <pineapple>6.0</pineapple>**
**MY FINAL DECISION: <orange>Accept</orange>**